Suppr超能文献

对联合化疗有反应的结肠鳞状细胞癌:两例报告及文献复习

Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature.

作者信息

Juturi J V, Francis B, Koontz P W, Wilkes J D

机构信息

Department of Internal Medicine, Ellis Fischel Cancer Center, University of Missouri-Columbia School of Medicine, USA.

出版信息

Dis Colon Rectum. 1999 Jan;42(1):102-9. doi: 10.1007/BF02235191.

Abstract

PURPOSE

The majority of colorectal neoplasms diagnosed are adenocarcinomas. Other histologies such as squamous, adenosquamous, carcinoid tumors, or lymphoid tumors are occasionally identified. Given the rarity of squamous-cell tumors, it is very difficult to study their natural course and response to therapy. An attempt is made to describe the frequency, anatomic location, and response to therapy with a review of the literature.

METHODS

From the Cancer Registry at the University of Missouri-Columbia Ellis Fischel Cancer Center, tumors of the colon identified above the dentate line were selected for chart review. Data were extracted from cases between the years 1940 and 1996. The key terms used to identify cases were epidermoid, squamous cell, and cancer of the rectum or colon. Using this approach, forty patients were identified and each record was reviewed.

RESULTS

The majority of these cases were anal cancers with proximal extension into the rectum and were excluded. Of 4,561 cases of epithelial colon and rectal cancers identified, only one additional case of squamous-cell cancer could be verified. In this report we describe a patient with a primary squamous-cell carcinoma of the sigmoid colon with metastatic disease to the liver at diagnosis who responded to systemic chemotherapy. We believe this to be the first reported case of this rare tumor type in which the patient's tumor responded to systemic chemotherapy. Two cases with a thorough review of literature are presented.

CONCLUSIONS

Primary squamous-cell carcinoma of the colon is a rare malignancy of unknown cause and pathogenesis. Metastatic tumors to the colon should be ruled out in all cases before therapy. Early detection and surgery remain the main therapeutic options, but as presented in our case, response to chemotherapy in advanced disease is encouraging.

摘要

目的

大多数被诊断出的结直肠肿瘤是腺癌。其他组织学类型,如鳞状细胞癌、腺鳞癌、类癌肿瘤或淋巴瘤,偶尔也会被发现。鉴于鳞状细胞肿瘤较为罕见,很难研究其自然病程和对治疗的反应。本文通过文献回顾,试图描述其发病率、解剖位置及对治疗的反应。

方法

从密苏里大学哥伦比亚分校埃利斯·菲舍尔癌症中心的癌症登记处选取齿状线以上的结肠肿瘤病例进行病历回顾。数据提取自1940年至1996年期间的病例。用于识别病例的关键词为表皮样、鳞状细胞以及直肠或结肠癌。通过这种方法,共识别出40例患者,并对每份病历进行了审查。

结果

这些病例中的大多数是肛管癌并向直肠近端扩展,因此被排除。在4561例已确诊的结肠和直肠上皮癌病例中,仅额外核实到1例鳞状细胞癌病例。在本报告中,我们描述了1例乙状结肠原发性鳞状细胞癌患者,诊断时已有肝转移,该患者对全身化疗有反应。我们认为这是首例报道的该罕见肿瘤类型患者的肿瘤对全身化疗有反应的病例。本文还呈现了2例病例并对文献进行了全面回顾。

结论

结肠原发性鳞状细胞癌是一种病因和发病机制不明的罕见恶性肿瘤。在所有病例治疗前均应排除转移至结肠的肿瘤。早期检测和手术仍然是主要的治疗选择,但正如我们病例中所示,晚期疾病对化疗的反应令人鼓舞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验